Other languages Vera Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 01:40:32 2024-05-10 pm EDT			5-day change	1st Jan Change
40.44 ^USD	-4.48%		-7.34%	+161.70%

11:49am	Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating	MT
May. 09	Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Wall Street herstelt na rentevrees	Apr. 11
Wall Street koerst overwegend hoger	Apr. 11
Wall Street koerst af op vlakke opening	Apr. 11
Aktien New York Ausblick: Vor dem Start in die Berichtssaison stabil erwartet	Apr. 11
Futures wijzen op lagere opening Wall Street	Apr. 11
Sector Update: Health Care Stocks Steady Premarket Wednesday	Mar. 20
Vera Therapeutics' 2023 Loss Narrows	Mar. 20
Vera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
Top Premarket Decliners	Feb. 28
Vera Therapeutics Insider Bought Shares Worth $4,999,990, According to a Recent SEC Filing	Feb. 01
Sector Update: Health Care Stocks Steady Premarket Monday	Jan. 29
Vera Therapeutics to Offer $200.0 Million of Class A Common Stock	Jan. 29
Top Midday Gainers	Jan. 26
Sector Update: Health Care Stocks Softer Late Afternoon	Jan. 25
Top Midday Gainers	Jan. 25
Sector Update: Health Care Stocks Slipping Thursday Afternoon	Jan. 25
Vera Therapeutics Shares Surge on 'Positive' Data From Extended Atacicept Phase 2 Study	Jan. 25
Vera Therapeutics, Inc. Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b Origin Clinical Trial Ole in IgA Nephropathy	Jan. 25
Vera Therapeutics, Inc. Announces Executive Changes	Jan. 08

No results for this search